66 related articles for article (PubMed ID: 23534669)
1. Use of narrow mass-window, high-resolution extracted product ion chromatograms for the sensitive and selective identification of protein modifications.
Spickett CM; Reis A; Pitt AR
Anal Chem; 2013 May; 85(9):4621-7. PubMed ID: 23534669
[TBL] [Abstract][Full Text] [Related]
2. Mapping oxidations of apolipoprotein B-100 in human low-density lipoprotein by liquid chromatography-tandem mass spectrometry.
Chakraborty S; Cai Y; Tarr MA
Anal Biochem; 2010 Sep; 404(2):109-17. PubMed ID: 20470747
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
[TBL] [Abstract][Full Text] [Related]
4. Targeted mass spectrometry methods for detecting oxidative post-translational modifications.
Tveen-Jensen K; Reis A; Spickett CM; Pitt AR
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S52-3. PubMed ID: 26461406
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric characterization of peptides containing different oxidized tryptophan residues.
Todorovski T; Fedorova M; Hoffmann R
J Mass Spectrom; 2011 Oct; 46(10):1030-8. PubMed ID: 22012669
[TBL] [Abstract][Full Text] [Related]
6. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
[TBL] [Abstract][Full Text] [Related]
7. Characterization of oxidized phospholipids in oxidatively modified low density lipoproteins by nanoflow liquid chromatography-tandem mass spectrometry.
Lee JY; Lim S; Park S; Moon MH
J Chromatogr A; 2013 May; 1288():54-62. PubMed ID: 23523068
[TBL] [Abstract][Full Text] [Related]
8. Strategy for identification and detection of multiple oxidative modifications within proteins applied on persulfate-oxidized hemoglobin and human serum albumin.
Mörtstedt H; Jeppsson MC; Ferrari G; Jönsson BA; Kåredal MH; Lindh CH
Rapid Commun Mass Spectrom; 2011 Jan; 25(2):327-40. PubMed ID: 21192028
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
[TBL] [Abstract][Full Text] [Related]
10. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
Li GX; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
[TBL] [Abstract][Full Text] [Related]
11. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation.
Aldini G; Regazzoni L; Orioli M; Rimoldi I; Facino RM; Carini M
J Mass Spectrom; 2008 Nov; 43(11):1470-81. PubMed ID: 18457351
[TBL] [Abstract][Full Text] [Related]
12. Influence of HSA and IgG on LDL oxidation studied by size-exclusion chromatography and phospholipid profiling using MALDI tandem-mass spectrometry.
Stübiger G; Sobal G; Widhalm K; Belgacem O; Pock K
Chem Phys Lipids; 2011 Sep; 164(6):563-72. PubMed ID: 21684268
[TBL] [Abstract][Full Text] [Related]
13. Oxidative interaction of unpaired hemoglobin chains with lipids and proteins: a key for modified serum lipoproteins in thalassemia.
Altamentova SM; Marva E; Shaklai N
Arch Biochem Biophys; 1997 Sep; 345(1):39-46. PubMed ID: 9281309
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition by estrogens of the oxidative modifications of human lipoproteins.
Martín C; Barturen K; Martínez R; Lacort M; Ruiz-Larrea MB
J Physiol Biochem; 1998 Dec; 54(4):195-202. PubMed ID: 10225411
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of low-density lipoproteins produces levuglandin-protein adducts.
Salomon RG; Subbanagounder G; Singh U; O'Neil J; Hoff HF
Chem Res Toxicol; 1997 Jul; 10(7):750-9. PubMed ID: 9250408
[TBL] [Abstract][Full Text] [Related]
16. Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis.
Wang N; Li L
Anal Chem; 2008 Jun; 80(12):4696-710. PubMed ID: 18479145
[TBL] [Abstract][Full Text] [Related]
17. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of bovine serum albumin: identification of oxidation products and structural modifications.
Guedes S; Vitorino R; Domingues R; Amado F; Domingues P
Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2307-15. PubMed ID: 19575405
[TBL] [Abstract][Full Text] [Related]
19. Reporter ion-based mass spectrometry approaches for the detection of non-enzymatic protein modifications in biological samples.
Tveen-Jensen K; Reis A; Mouls L; Pitt AR; Spickett CM
J Proteomics; 2013 Oct; 92():71-9. PubMed ID: 23603107
[TBL] [Abstract][Full Text] [Related]
20. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
